Current Issue

View Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3

Robert Dream, Managing Director, HDR Company LLC

Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...

Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...

Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...

Lifetime Study for JSR Amsphere A3 – Protein A Resin

JSR Life Sciences

Featured Articles

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Overcoming Obstacles in AAV Viral Vector Manufacturing

Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection

View All Featured Articles

Careers

Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive

Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific

Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here

Jason Rudd, Amgen, Statistical Programming Manager

Inspiring the Next Generation at Bristol Myers Squibb

Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist

A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza

Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development

At Bayer We Foster an Environment of Openness and Understanding Not Pity

Jürgen Schrapp, Bayer, Head of R&D Procurement

The Best Thing About Evotec, Without Question, Is The People

Stuart Flanagan, Evotec, Group Leader

View All Careers Articles

Headline News

GSK finalises acquisition of Nuvalent

GSK shares update on CALM-1 and CALM-2 Phase III trials for camlipixant in refractory chronic cough

FDA and EMA accept regulatory submissions for cemdisiran for the treatment of generalised myasthenia gravis

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Machine Learning in Bioprocess Development: Where We Are and Where We Could Go

Presented by Rui Portela, Senior Data Scientist, GlaxoSmithKline Vaccines and Klaus Mauch, CEO at Insilico Biotechnology AG
06th May 2020

Patient-Centric Drug Delivery Strategies For Oral Paediatric Products

Presented by Dr. Carsten Timpe Senior Principal Scientist at Hoffman La Roche AG and Dr. Paolo Gatti Research Fellow and Formulation Manager for Aptalis Pharmaceutical Technologies
22nd April 2015

Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up

Presented by Presented by Dr. Jincai Li, Vice President of WuXi Biologics and Liang Tang, PhD, Vice President of WuXi Biologics and Sunil Chhatre, Sartorius Stedim Biotech
14th September 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos